Literature DB >> 29175360

Efficacy of Acupuncture Is Noninferior to Nicotine Replacement Therapy for Tobacco Cessation: Results of a Prospective, Randomized, Active-Controlled Open-Label Trial.

Ying-Ying Wang1, Zhao Liu2, Yuan Wu3, Li Yang1, Lang-Tao Guo4, Hao-Bin Zhang5, Jin-Sheng Yang6.   

Abstract

BACKGROUND: We designed and conducted this multicenter randomized active-controlled open-label trial to evaluate the efficacy of acupuncture, auricular point pressing, and nicotine replacement therapy (NRT) on tobacco cessation in the Chinese population.
METHODS: This randomized controlled trial was conducted in seven hospitals in China between October 2013 and February 2016. Eligible participants were recruited and randomly assigned to receive acupuncture or auricular point pressing or NRT via a central randomization system with a 1:1:1 ratio. All treatment was given for a total of 8 weeks, and follow-up visit was at 16 weeks. The primary outcome measure was carbon monoxide (CO)-confirmed 24-h point abstinence rate (<10 parts per million), 24 weeks after quit day.
RESULTS: A total of 300 participants were recruited and 195 participants finished, with a dropout rate of 35.00%. Two cases of adverse events in the acupuncture group and 2 cases in the NRT group were observed. The CO-confirmed 24-h point abstinence rate was 43.00% at 24 weeks in the acupuncture group, which was similar to 44.00% in the NRT group (P > .05), but significantly higher than the 30.00% in the auricular point group (P < .05). At 24 weeks, the Fagerstrom Nicotine Dependence Test and the Minnesota Nicotine Withdrawal Scale scores in the acupuncture group were significantly lower than those in the auricular point group and in the NRT group (P < .05). Kaplan-Meier analysis showed the time to relapse for acupuncture (44.12 days) was insignificantly longer than NRT (41.18 days), but significantly longer than auricular point pressing (29.53 days).
CONCLUSIONS: We found acupuncture was safe and a possible treatment for tobacco cessation, but it requires further study to establish its role. TRIAL REGISTRY: Chinese Clinical Trial Registry; No.: ChiCTR-TRC-13003544; URL: http://www.chictr.org.cn/abouten.aspx.
Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acupuncture; nicotine replacement therapy; randomized controlled trial; tobacco cessation

Mesh:

Year:  2017        PMID: 29175360     DOI: 10.1016/j.chest.2017.11.015

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  The efficacy and safety of acupuncture and nicotine replacement therapy for smoking cessation: study protocol for a randomized controlled trial.

Authors:  Qingsheng Wang; Runjing Dai; Hailiang Zhang; Xiaomei Jiang; Xiaojing Ma; Xiangrong Zhang; Shisan Bao; Dong Ren; Jingchun Fan
Journal:  Trials       Date:  2022-06-06       Impact factor: 2.728

2.  Effects of acupuncture on craving after tobacco cessation: a resting-state fMRI study based on the fractional amplitude of low-frequency fluctuation.

Authors:  Ying-Ying Wang; Zhao Liu; Feng Chen; Li Sun; Yuan Wu; Jin-Sheng Yang; Ji-Liang Fang
Journal:  Quant Imaging Med Surg       Date:  2019-06

3.  Acupuncture combined with auricular acupressure for smoking cessation and its effects on tobacco dependence and smoking behavior among Hong Kong smokers: a multicenter pilot clinical study.

Authors:  Lai Fun Ho; Wai Kwan Ho; Ling Ling Wong; Sze Wan Chiu; Shuk Yu Tang; Chun Ming Wong; Kin San Chan; Chi Lan Lam; Min Chen; Kam Leung Chan; Guohua Lin; Bacon Fung-Leung Ng; Zhi Xiu Lin
Journal:  Chin Med       Date:  2022-08-09       Impact factor: 4.546

4.  Efficacy and safety of acupuncture combined with auricular acupressure for smoking cessation: A study protocol of a multicentre, randomized, controlled clinical trial.

Authors:  Jinchun Zeng; Yizu Liao; Xiaojing Wei; Guangxian Chen; Zibin Cai; Min Chen; Yanhua Gou; Guohua Lin
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.